LCGC
MEDP icon

Legacy Capital Group California’s Medpace MEDP Stock Holding History

Legacy Capital Group California’s Portfolio MEDP Stock Details MEDP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$314K Sell
653
-135
-17% -$69.1K 0.12% 235
2025
Q4 		$443K Buy
+788
New +$447K 0.11% 232

Other funds holding MEDP

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Legacy Capital Group California's MEDP Position: Q1 2026 in Review

Legacy Capital Group California reduced its Medpace (MEDP) stake by 17% in Q1 2026, selling an estimated $69.1K and leaving 653 shares worth $314K. The position accounts for 0.12% of the portfolio, ranked #235.

Legacy Capital Group California first reported a position in MEDP in Q4 2025 and has held it in 2 quarters since. The position peaked at $443K in Q4 2025. 729 funds tracked by Wall St. Rank hold MEDP as of Q1 2026.

  • Legacy Capital Group California held 653 shares of Medpace worth $314K as of Q1 2026.
  • Legacy Capital Group California sold 135 Medpace shares in Q1 2026, an estimated $69.1K.
  • Medpace made up 0.12% of Legacy Capital Group California's portfolio in Q1 2026, its #235 holding.
  • Legacy Capital Group California first reported a position in Medpace in Q4 2025 and has held it in 2 quarters since.
  • Legacy Capital Group California's Medpace position peaked at $443K in Q4 2025.
  • 729 funds tracked by Wall St. Rank held Medpace as of Q1 2026.

Based on Legacy Capital Group California's 13F filing for Q1 2026, filed 4 May 2026.